Home/Filings/SCHEDULE 13D/A/0001072613-25-000239
SCHEDULE 13D/A//SEC Filing

Trevi Therapeutics, Inc. SCHEDULE 13D/A

Accession 0001072613-25-000239

CIK 0001694560other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 7:55 PM ET

Size

105.9 KB

Accession

0001072613-25-000239

Issuer

New Enterprise Associates 16, L.P.

CIK 0001694560

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001694560

Filing Metadata

Form type
SCHEDULE 13D/A
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:55 PM ET
Size
105.9 KB